The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $83.35

Today's change+1.88 +2.31%
Updated December 2 4:02 PM EST. Delayed by at least 15 minutes.
 

Edwards Lifesciences Corp

NYSE: EW
Last

(U.S.) $83.35

Today's change+1.88 +2.31%
Updated December 2 4:02 PM EST. Delayed by at least 15 minutes.

Edwards Lifesciences Corp up sharply

Edwards Lifesciences Corp closed up sharply Friday, rallying (U.S.)$1.88 or 2.31% to (U.S.)$83.35. Shares have lost 2.86% over the last five days, but have gained 5.53% over the last year to date. This security has underperformed the S&P 500 by 3.05% during the last year.

Key company metrics

  • Open(U.S.) $81.44
  • Previous close(U.S.) $81.47
  • High(U.S.) $84.66
  • Low(U.S.) $81.25
  • Bid / Ask-- / --
  • YTD % change+5.53%
  • Volume2,324,500
  • Average volume (10-day)2,436,947
  • Average volume (1-month)3,148,200
  • Average volume (3-month)1,848,110
  • 52-week range(U.S.) $72.20 to (U.S.) $121.75
  • Beta0.61
  • Trailing P/E32.96×
  • P/E 1 year forward28.95×
  • Forward PEG1.67×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $2.53
Updated December 2 4:02 PM EST. Delayed by at least 15 minutes.
S&P TSX0.17%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue739759697671
Total other revenue--------
Total revenue739759697671
Gross profit538557517495
Total cost of revenue201203180176
Total operating expense554590514504
Selling / general / administrative230229213222
Research & development11311310298
Depreciation / amortization--------
Interest expense (income), net operating------5
Unusual expense (income)744123
Other operating expenses, total3951
Operating income185169183167
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax185169183167
Income after tax141127143141
Income tax, total44424026
Net income141127143141
Total adjustments to net income--------
Net income before extra. items141127143141
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items141127143141
Inc. avail. to common incl. extra. items141127143141
Diluted net income141127143141
Dilution adjustment0--01
Diluted weighted average shares218217218221
Diluted EPS excluding extraordinary itemsvalue per share0.650.580.660.64
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.670.730.700.65